Breanna Barry
Family · Houston, TXNPI 1649892753
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 27.0% of the total. Reporting peaked in 2022 at $1,030 and has fallen 51.3% since, to $501 in 2023.
Across 130 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$571
- AbbVie$357
- Coopersurgical, Inc.$150
- Astellas Pharma US Inc$149
- Avion Pharmaceuticals$141
- Exeltis, USA Inc.$132
- plus $615 from 15 others
What the payments were for
- Food & beverage$2,01595%
- Education$1005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 41 | $571 |
| AbbVie | 26 | $357 |
| Coopersurgical, Inc. | 7 | $150 |
| Astellas Pharma US Inc | 4 | $149 |
| Avion Pharmaceuticals | 8 | $141 |
| Exeltis, USA Inc. | 7 | $132 |
| Pfizer | 6 | $92 |
| Therapeuticsmd, Inc. | 7 | $92 |
| Myovant Sciences Inc. | 4 | $79 |
| Evofem Biosciences, Inc. | 4 | $70 |
| Mycovia Pharmaceuticals, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Agile Therapeutics, Inc. | 3 | $38 |
| Scynexis, Inc. | 2 | $33 |
| Smith+Nephew | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Mylan Pharmaceuticals Inc. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Organon | 1 | $14 |
| Novo Nordisk | 1 | $13 |
How this compares
$2,115 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Other family in Houston
- Robin BeachHouston$428K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- Kendrick ClackHouston$28K
- David WeirDallas$959K
- April LopezMcAllen$417K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.